Microbiome Treatment Market By Product Type (Probiotics, Prebiotics, Synbiotics, Postbiotics, Microbiome Drugs, Fecal Microbiota Transplantation), By Application (Gastrointestinal Disorders, Metabolic Disorders, Neurological Disorders, Skin Disorders, Cancer Treatment, Others), By Route of Administration (Oral, Topical, Injectable), By End-user (Hospitals & Clinics, Research Institutes, Pharmaceutical & Biotechnology Companies, Specialty Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Probiotics
• Prebiotics
• Synbiotics
• Postbiotics
• Microbiome Drugs
• Fecal Microbiota Transplantation

By Application

• Gastrointestinal Disorders
• Metabolic Disorders
• Neurological Disorders
• Skin Disorders
• Cancer Treatment
• Others

By Route of Administration

• Oral
• Topical
• Injectable

By End-user

• Hospitals & Clinics
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Specialty Centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Seres Therapeutics
• Enterome Bioscience
• Assembly Biosciences, Inc.
• Finch Therapeutics Group, Inc.
• BiomeSense
• Axial Therapeutics, Inc.
• Synlogic
• Pendulum
• Vedanta Biosciences, Inc.
• AbbVie Inc.
• Ferring
• AOBiome
• Immuron Ltd.
• Pfizer Inc.
• Bayer AG